According to United Therapeutics's latest financial reports the company's total liabilities are $1.18 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $1.18 B | -5.26% |
2022-12-31 | $1.24 B | 3.11% |
2021-12-31 | $1.21 B | -0.79% |
2020-12-31 | $1.21 B | 7.66% |
2019-12-31 | $1.13 B | 91% |
2018-12-31 | $0.59 B | -21.78% |
2017-12-31 | $0.75 B | 63.66% |
2016-12-31 | $0.46 B | -20.75% |
2015-12-31 | $0.58 B | -5.52% |
2014-12-31 | $0.61 B | -20.99% |
2013-12-31 | $0.78 B | 47.3% |
2012-12-31 | $0.53 B | -4.83% |
2011-12-31 | $0.55 B | 2% |
2010-12-31 | $0.54 B | 37.44% |
2009-12-31 | $0.39 B | 24.85% |
2008-12-31 | $0.31 B | 9.6% |
2007-12-31 | $0.29 B | 6.93% |
2006-12-31 | $0.27 B | 1569.82% |
2005-12-31 | $16.31 M | 5.08% |
2004-12-31 | $15.52 M | 32.25% |
2003-12-31 | $11.73 M | -9.07% |
2002-12-31 | $12.9 M | -17.9% |
2001-12-31 | $15.72 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $137.21 B | 11,506.58% | ๐บ๐ธ USA |
Eli Lilly LLY | $53.14 B | 4,395.23% | ๐บ๐ธ USA |
Baxter BAX | $19.80 B | 1,575.52% | ๐บ๐ธ USA |
Gilead Sciences GILD | $39.37 B | 3,230.74% | ๐บ๐ธ USA |
Cardinal Health CAH | $50.02 B | 4,131.09% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $58.82 B | 4,875.92% | ๐ฌ๐ง UK |
Cytokinetics
CYTK | $1.21 B | 2.41% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $35.35 B | 2,890.44% | ๐ฎ๐ฑ Israel |